Clinical value and measurement of specific IgE.
The diagnosis of human allergic diseases involves the combined use of a careful clinical history, physical examination, and in vitro and in vivo assay methods for the detection of IgE antibodies of defined allergen specificities. In vivo (skin testing) and in vitro (measurement of specific IgE in serum) techniques cannot be considered interchangeable, the former reflecting not only the presence of IgE but also mast cell integrity, vascular and neural responsiveness. Both techniques have similarities and differences, advantages and disadvantages. Recently introduced "second generation" immunoassays have continued to improve the analytical sensitivity and reproducibility thanks to automation and improved reagent quality. Quantitative assays may allow the use of specific clinical thresholds able to differentiate symptomatic from asymptomatic patients. False-negative and false-positive results should derive from lability of some major extracts, and from possible cross-reactivities, respectively. Characterization of allergens at a molecular and submolecular level and, where necessary, the use of recombinant allergens can reduce cross-reactions and further improve the quality of immunoassays.
Plebani
Mario
M
Department of Laboratory Medicine, University-Hospital of Padova, and Centre for Biomedical Research, Castelfranco, Veneto, Italy. mario.plebani@sanita.padova.it
D000485:Allergens / Q000276:immunology; D000918:Antibody Specificity; D003429:Cross Reactions; D003951:Diagnostic Errors; D006801:Humans; D006967:Hypersensitivity / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D007114:Immunization; D007118:Immunoassay; D007073:Immunoglobulin E / Q000032:analysis* / Q000096:biosynthesis / Q000097:blood; D015592:Immunoradiometric Assay; D015995:Prevalence; D011786:Quality Control; D011994:Recombinant Proteins / Q000276:immunology; D012015:Reference Standards; D012882:Skin Tests
D000485:Allergens; D011994:Recombinant Proteins; D007073:Immunoglobulin E